Reviv Global and partner V-Health Passport are backing their technology to allow the hospitality industry to reopen safely in resorts such as Las Vegas.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS